Tip sheet for the August 24, 2004 Neurology journal

August 23, 2004

Mental decline is more severe in elderly women with diabetes and pre-diabetes
The study of 7,027 women, led by Kristine Yaffe, MD, of University of California, San Francisco, found that those with pre-diabetes as well as those with diabetes have worse cognitive performance, and are at an increased risk for developing cognitive impairment, including mild cognitive impairment and dementia.

A related Neurology Patient Page, written by Janet Jankowiak, MD, provides background on why increased obesity and excessive sugar consumption are to be avoided because of their ties to cognitive decline. The Patient Page also includes an explanation of dementia, the different types of dementia, how they are treated, warning signs and how to respond when you suspect dementia in a family member. The Patient Page will be available for downloading from www.neurology.org on August 24, or can be obtained in advance from AAN media relations staff.

Moderate economic value equated with treatment of severe Alzheimer's disease
Feldman et al report on the pharmacoeconomics of donepezil treatment of severe Alzheimer's disease. They report that donepezil treatment for six days within a randomized, placebo-controlled trial is associated with a total societal cost saving of $224 per patient.

Other news
The American Academy of Neurology and the Society for Neuroscience have joined with multiple patient advocacy groups, foundations, and professional organizations to establish the American Brain Coalition (ABC). ABC's mission is to reduce the burden of brain disorders to individuals, families, and society. The vision for ABC is to develop a strong voice for people with disorders of the nervous system and advocate for increased support for biomedical research. The interim chair of ABC is Francis Kittredge, Jr., MD, who was a driving force for the creation of the organization during his term as president of the AAN in 2000-2001. For more information contact Kathy Stone, American Academy of Neurology, kstone@aan.com, or Allison Kupferman, Society for Neuroscience, allison@sfn.org.
-end-
The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Parkinson's disease, ALS (Lou Gehrig's disease), dementia, West Nile virus, and ataxia.

For more information about the American Academy of Neurology, visit its Website at www.aan.com.

American Academy of Neurology

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.